Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian S Ray

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2017
Transporter Expression in Noncancerous and Cancerous Liver Tissue from Donors with Hepatocellular Carcinoma and Chronic Hepatitis C Infection Quantified by LC-MS/MS ProteomicsSarah Billington, Adrian S Ray, Laurent Salphati, et al.
Scientific Reports|March 7, 2017
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and ParamyxovirusesMichael K Lo, Robert Jordan, Aaron Arvey, et al.
Antimicrobial Agents and Chemotherapy|December 7, 2007
Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131Tomas Cihlar, Adrian S Ray, Constantine G Boojamra, et al.
Gastroenterology|July 31, 2018
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver DiseaseRohit Loomba, Zeid Kayali, Mazen Noureddin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphomaDavid M Vail, Douglas H Thamm, Hans Reiser, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2012
Metabolic activation of the anti-hepatitis C virus nucleotide prodrug PSI-352938Congrong Niu, Tatiana Tolstykh, Haiying Bao, et al.
Bioorganic & Medicinal Chemistry|January 31, 2009
Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitorsConstantine G Boojamra, Jay P Parrish, David Sperandio, et al.
Mbio|March 8, 2018
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading ExoribonucleaseMaria L Agostini, Erica L Andres, Amy C Sims, et al.
Journal of Virology|April 29, 2011
Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitorsJ Gerardo García-Lerma, Wutyi Aung, Mian-er Cong, et al.
Plos Pathogens|November 21, 2012
Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosidesJamie J Arnold, Suresh D Sharma, Joy Y Feng, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2017
Transporter Expression in Noncancerous and Cancerous Liver Tissue from Donors with Hepatocellular Carcinoma and Chronic Hepatitis C Infection Quantified by LC-MS/MS ProteomicsSarah Billington, Adrian S Ray, Laurent Salphati, et al.
Scientific Reports|March 7, 2017
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and ParamyxovirusesMichael K Lo, Robert Jordan, Aaron Arvey, et al.
Antimicrobial Agents and Chemotherapy|December 7, 2007
Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131Tomas Cihlar, Adrian S Ray, Constantine G Boojamra, et al.
Gastroenterology|July 31, 2018
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver DiseaseRohit Loomba, Zeid Kayali, Mazen Noureddin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphomaDavid M Vail, Douglas H Thamm, Hans Reiser, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2012
Metabolic activation of the anti-hepatitis C virus nucleotide prodrug PSI-352938Congrong Niu, Tatiana Tolstykh, Haiying Bao, et al.
Bioorganic & Medicinal Chemistry|January 31, 2009
Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitorsConstantine G Boojamra, Jay P Parrish, David Sperandio, et al.
Mbio|March 8, 2018
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading ExoribonucleaseMaria L Agostini, Erica L Andres, Amy C Sims, et al.
Journal of Virology|April 29, 2011
Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitorsJ Gerardo García-Lerma, Wutyi Aung, Mian-er Cong, et al.
Plos Pathogens|November 21, 2012
Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosidesJamie J Arnold, Suresh D Sharma, Joy Y Feng, et al.
Pageof 11